Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
clinical trials
national top stories
san francisco blog main
startups
acute myeloid leukemia
adverum biotechnologies
ally bridge group
ambit biosciences
artificial intelligence
athena countouriotis
big data analytics
black diamond therapeutics
blackrock
bladder cancer
blueprint medicines
boston
brett zbar
bristol-myers squibb
cancer
cancer drugs
casdin capital
cormorant asset management
daiichi sankyo
deciphera pharmaceuticals
diabetic nephropathy
eli lilly
endometral cancer
europe blog main
european society for medical oncology
eventide asset management
fda
focal segmental glomerulosclerosis
glioblastoma
goldfinch bio
halozyme therapeutics
What
biotech
4
×
drug
4
×
new
4
×
medicines
cancer
ipo
lead
million
raised
ready
research
therapeutics
algorithms
analysis
athena
batch
bio
black
bottlenecks
bring
called
ceo
chief
clinic
clinical
combinator’s
companies
company
cost
countouriotis
develop
developing
development
diamond
diseases
dollars
drugs
eluded
employing
financing
Language
unset
Current search:
biotech
×
drug
×
new
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
